Hugo Alves, Co-Founder & CEO, Auxly Cannabis Group


A cannabis industry pioneer, Hugo has played a key role in shaping the regulated cannabis industry in Canada, including acting as counsel and advisor to many of the industry's leading companies, brands, industry associations, patient access groups and cannabis focused events and conferences. He is also the co-founder of Hope for Health, the world's first registered charity focused on providing access to medical cannabis and the advancement of knowledge relating to medical cannabis. Hugo is an adjunct professor at the University of Western Ontario Law School, where he co-created and teaches Cannabis Law and Practice, the first cannabis-focused course ever offered at a Canadian law school.Prior to founding Auxly, Hugo was a senior corporate and commercial Partner at Bennett Jones LLP, where he built the firm's cannabis practice group and advised Canadian and foreign clients in connection with private mergers and acquisitions, public and private financings, public procurements, outsourcing transactions, joint ventures and strategic alliances. Hugo obtained his BA from Carleton University, where he won the Senate Medal for Outstanding Academic Achievement and obtained his Doctor of Law from the University of Toronto.

Auxly is an international cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the medical, wellness and adult-use markets. Auxly’s experienced team of industry first-movers and enterprising visionaries has secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading product research and development infrastructure in order to create trusted products and brands in an expanding global market. Auxly’s vision is to be a global cannabis leader focused on providing branded cannabis products backed by science and innovation.

Experienced Team Dedicated To Growth. A leadership team of industry first-movers, enterprising visionaries, and deep subject matter experts; team with unique expertise positions the company to successfully execute its strategy 
Vertically Integrated Infrastructure Captures Benefits Across The Value Chain. High-quality portfolio of assets that crosses all facets of the cannabis business, from cultivation and extraction through to product development, manufacturing and retail 
Science-Backed, Innovative Product Development. Extraction, product development and manufacturing capabilities focused on developing science-backed derivative cannabis products in time for the legalization of edibles, extracts and topicals later this year 
Clinical Trials & Efficacy Research. In-house ability to test products through clinical trials and substantiate claims 
Focus On Safety And Quality. Upholding commitments to high standards, rigorous testing and our duty to the consumer 
Thoughtful Brand Development. Internally developed and third-party licensed brands designed to target a broad market, including medical, wellness and adult-use and price points across across all markets


Columbia Care Inc. is one of the largest and most experienced multi-state operators in the medical cannabis industry, with licenses in 15 jurisdictions in the US and the EU.


With over 1.2 million sales transactions since its inception, Columbia Care is a patient-centered organization setting the standard for compassion, professionalism, quality, caring and innovation, working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the world. The Company is committed to providing the type of education and transparency patients deserve and quality of product that clinicians expect.

Nicholas Vita, Co-Founder & CEO, Columbia Care


Nicholas Vita co-founded Columbia Care in 2012 and serves as Chief Executive Officer. Nicholas has over 25 years of experience serving in corporate leadership roles, investing capital, structuring and funding public/private partnerships and providing strategic advisory services to Fortune 500 companies throughout the U.S., Europe, Asia and Latin America. Prior to Columbia Care, Nicholas was a Partner and served as the Chairman of the Investment Committee at Apelles Investment Management, LLC, a private investment management company focused on the healthcare and privatized military infrastructure sectors. Before Apelles, Nicholas was a General Partner, member of the Investment Committee, and the Portfolio Manager for the Healthcare Sector at ARX Investment Management. Previously, he worked in the Investment Banking Division at Goldman Sachs & Co. Inc., as an Analyst, Associate and Vice President in the Healthcare Department focused on Mergers, Raid Defense and Corporate Finance. He is a graduate of Columbia College, Columbia University where he was a member of the Men’s Varsity Heavyweight Crew Team.

Brad Rogers, CEO - Red White & Bloom

Prior to joining RWB, Brad served as President of CannTrust, one of the largest licensed cannabis producers in Canada.  Brad was part of the team that built Mettrum, and one of the first commercially scaled production facilities in the world for medical cannabis. Mettrum was successfully sold in 2016 to Canopy Growth for over CDN $450 million.
Brad also has experience in the marketing and entertainment sector, creating brands and products for blue-chip companies and distributed through some of the biggest names in global retail.



Led by a refined group of experts with a proven track record of building highly successful, profitable businesses in the cannabis sector with market valuations exceeding $2.5 billion, Red White & Bloom’s current operations have put them on the map as one of the top 5 multi-state operators.
With operations currently extended across 4 states, with rapid, strategic expansion set to follow. RWB's footprint covers 4 million square feet of cultivation, processing and dispensary space on 32 sites staffed by 800+ employees (subject to closing of all open binding acquisition agreements). 
As well, RWB's expanding portfolio includes superior products focused on a “house of brands” strategy in both cannabis and hemp-derived product lines.
Red White & Bloom is dedicated to building the biggest and best cannabis and CBD company in the world, to create and deliver the top quality, consistent products Americans deserve.


Canopy Rivers (TSX:RIV) (OTC:CNPOF) is a cannabis venture capital investment and operating platform. The Company is managed by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks; but what makes Canopy Rivers truly unique is the Company’s strategic partnership and cornerstone investment from Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers works collaboratively with Canopy Growth to identify strategic counterparties seeking financial and/or operating support and affiliation with the Canopy Growth group of companies. The result is an ecosystem of complementary companies operating throughout the cannabis value chain. As the portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves, which the company believes results in an ideal environment for innovation, synergy, and value creation for Canopy Rivers, Canopy Growth, and across the entire Rivers ecosystem.

Eddie Lucarelli - CFO, Canopy Rivers

Prior to joining Canopy Rivers, Eddie was a Vice President in the Mergers & Acquisitions group at TD Securities. His team provided sell-side and buy-side M&A advisory services to large and mid-cap Canadian companies. During his time at TD, Eddie worked on several transformative transactions in the telecommunications, media, and real estate industries.

Eddie began his career at Deloitte LLP where he became a Senior Manager in the firm's Financial Advisory practice. He advised domestic and international clients across a variety of industries on business valuation matters for transaction, tax, audit, accounting, litigation and other purposes. During his time at Deloitte, Eddie also helped execute the firm's global financial advisory strategy and completed a placement in London, England. Eddie holds a Bachelor of Commerce from the Smith School of Business at Queen's University. He is a Chartered Professional Accountant and a Chartered Business Valuator.

The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets.

Richard Carleton, CEO - CSE

Richard Carleton has been CEO of the Canadian Securities Exchange for seven years. Prior to this appointment, Richard served as Vice-President Corporate Development with responsibility for the CSE’s technology, operations, market data and trading sales teams. Before joining the exchange, Richard worked as a business development consultant in Toronto and New York in the risk management and index product fields after spending twelve years with the Toronto Stock Exchange, serving most recently as a member of the exchange’s senior management team. Active in industry affairs, Richard served two terms as chair of the market data industry’s global trade association in the late 1990's and is a frequent panelist at market structure and trading technology events across North America. Richard also serves as a member of the boards of the Private Capital Markets Association and the Empire Club of Canada.

A member of the Law Society of Upper Canada since 1987, Richard is a graduate of the University of Ottawa (B.A. ’81) and the University of Toronto (LL.B. ’85). He has also completed the executive development programme at the Wharton School, University of Pennsylvania.

Francisco Ortiz von Bismarck - CEO, Terrace Global Inc.

Francisco Ortiz von Bismarck is an international entrepreneur and founder of Terrace, who brings extensive investment experience across Europe and South America. Mr. Ortiz von Bismarck has been an entrepreneur and investor since he finished university. In 2006, he co-founded and was the first investor of the “Spanish Facebook”, called “Tuenti”, sold to Telefonica in 2010. In 2008, he co-founded and was the majority shareholder in a project called Glass which he sold the Glass trademark to Google in 2014. From 2009 until 2018, Mr. Ortiz von Bismarck was the Business Development Manager of GT Group, a multi-family wealth management firm based in Zürich, Switzerland. In 2011, Mr. Ortiz von Bismarck co- founded Inception Capital S.L., a venture capital fund focused in seed Internet investments in Spain. Over the years, Mr. Ortiz von Bismarck created and invested in several other tech start-ups such as Youzee Entertainment in Spain (2011), Dupli Limited in Malta (2014), and Y Experiment in Poland (2015) with limited traction. Mr. Ortiz von Bismarck is also an advisor (2016) and director (2017) in Easy Payment Gateway in Gibraltar. Until recently, he was a director (2016- 2018) in Agriculture Investment Group Corp. with assets in Uruguay. Mr. Ortiz von Bismarck holds a Bachelor Degree in Economics from Harvard University. 

Terrace Global Inc.

Terrace Global is a multi-country operator (MCO) led by experienced cannabis entrepreneurs focused on the development and acquisition of international cannabis assets. Terrace Global’s focus is on federally legal jurisdiction with existing domestic demand, low cost inputs and approved for exportation. Terrace Global’s existing asset platform consist of:  (1) a 33.75% equity interest in one of two recreational cannabis operations in Uruguay; (2) 100% of Oransur, S.A., a Uruguayan company producing high CBD hemp in Uruguay; (3) 100% of Terra Nova Produção e Comercialização de Produtos Natuis e Farmacêuticos, Lda, a Portuguese company with a pre-license issued by INFARMED for the cultivation, importation, and exportation of medical cannabis in Portugal; and (4) 100% Pharmabinoide S.L., a Spanish corporation producing and commercializing hemp in Spain. Terrace Global has a strategic partnership with MariMed Inc. (OTC – MRMD), a leading multi-state operator in the U.S

Geoff Benic, CEO - Aleafia Inc.

Widely known for his role in helping to create and build the iconic Grocery Gateway brand, Benic’s career has been characterized by success in many highly demanding environments. Previously regional director of United Parcel Service Canada, one of the world’s most rigorous and demanding global logistics entities, Benic moved on to be an initial Grocery Gateway employee and General Manager. From October 2004 until June 2018, Benic was the founder and chairman of Sofilia Logistics Group Inc., a leading National Delivery Logistics Service, where he followed a vertical integration growth strategy and successfully acquired and integrated mid-market businesses. His capital-raising abilities have been significant and include several mergers and acquisitions and eventual sales to larger companies.

Aleafia Health brings Canadians medical cannabis care through nationwide clinics, world-class cultivation and distribution facilities, and innovative research. Experiential knowledge of medical cannabis therapy, a rapidly evolving science, helps ensure physicians make recommendations that have been proven effective through historical data, helping to avoid treatments based on trial and error. The company’s staff of trained educators provide learning sessions for new patients, providing ongoing consultation ensuring patients are matched with the most appropriate treatment.

MPX International Corporation is focused on developing and operating assets across the global cannabis industry with an emphasis on cultivating, manufacturing and marketing products which include cannabinoids as their primary active ingredient.

Russell Star, President- Pivot Pharmaceuticals

Russell has held senior positions and advisory roles with financial institutions including RBC Capital Markets, Scotia Capital, Orion Securities, Blackmont, Lawrence and Company, where he helped raise over a billion dollars for junior and mid-tier companies. Russell is also a co-founder and part owner of Echelon Wealth Partners, a large Canadian investment dealer.

After leaving Bay Street, Russell held an executive position and board appointment with Cayden Resources, acquired by Agnico Eagle in 2014. As a SVP with Cayden Resources and board member, Russell was integral in the marketing, financing, development and ultimate sale of Cayden for CAD$205 million to Agnico Eagle.

Russell holds a MBA from the Richard Ivey School of Business, a Master of Arts degree in Economics from the University of Victoria and a Bachelor of Arts degree in Economics from Queens University. Russell was also a PhD candidate at McGill University in Econometrics.

Pivot Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Our shares are publicly-traded on the CNX under the ticker symbol “PVOT” and on the OTCQB under the ticker symbol “PVOTF". 

Bob Brilon, President & CFO - Vext Science

Bob has an entrepreneurial history of taking companies public from the ground floor and launching emerging patented technologies.

His goal is to increase shareholder value through organic growth of existing Medical Marijuana cultivation and dispensary in Arizona as well as acquisition of additional similar revenue streams in US, Canada, and Worldwide

Specialties: Mergers and Acquisition, Equity Market Capital, Technology Licensing, Cannabis, Medical Marijuana

Vext Science, Inc. is a US-based Cannabis THC and Hemp cannabinoid products company manufacturing THC cartridges, concentrates, edibles and accessories under the Vapen™ Brand, and Hemp based products under the Pure Touch Botanicals brand as well as the Vapen CBD brand. Based in Arizona, Vext Science has one of the leading THC concentrates, edibles, and distillate cartridge brands sold in the majority of the state's 100+ dispensaries. Herbal Wellness Center is one of Arizona's leading dispensaries and we execute all aspects of the cultivation, extraction, edibles infusion and manufacturing processes which insures a product of the highest quality and purity. Product quality and purity are core to our marketing strategy. Vext Science is executing its business growth by leveraging experience and expertise in extractions, product manufacturing, and marketing to expand in the U.S. and internationally through revenue and profit-sharing joint venture partnerships. For more information visit our website at [].

Heritage is focused on becoming a vertically integrated cannabis provider that currently has two Health Canada approved licenced producers, through its subsidiaries Voyage Cannabis and CannaCure Corp. both regulated under the Cannabis Act Regulations. Working under these two licences, Heritage has two additional subsidiaries, Purefarma Solutions, which provides extraction services, and BriteLife Sciences which is focused on cannabis based medical solutions. Heritage as the parent company, is focused on providing the resources for its subsidiaries to advance their products or services to compete both domestically and internationally.

Clint Sharples, CEO - Heritage Cannabis

Clint is a partner in a private equity management company formed in 2005. His primary roles are CEO of Modu-Loc Fence Rentals a Canada’s Best Managed Company, and Chairman of Strategic Aviation and Sky Café. He is responsible for over 1,200 employees and $80 million in annual revenues. His primary role with Heritage is to lead the overall corporate development and implementation of the strategic direction.

IM Cannabis Corp.

International Medical Cannabis (“IMC”) is a leading medical cannabis provider. Since 2010, the company has offered a full spectrum of government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. IMC is an industrial innovator, constantly moving forward in the rapidly developing medical cannabis market and closely collaborating with research institutions and start-up companies.
IMC is based in Israel & expanding internationally, currently focusing on the EU market. IMC initiated its strategy by acquiring a pharmaceutical distribution company in Germany with all licenses required for distribution of medical cannabis throughout Europe. IMC’s supply of EU-GMP pharma-grade medical cannabis products is available from a variety of sources, both EU cultivation farms, as well as Israeli farms. The company operates a large industrial facility in compliance with strict medical cannabis laws and regulations ensuring world-class safety and quality standards. IMC has formed strong strategic alliances within the international medical cannabis industry and has developed a long-term, IP-protected product portfolio.

Oren Shuster - CEO & Director

Oren is the co-founder and Chief Executive Officer of International Medical Cannabis (IMC) and one of Israel’s prominent experts in the field of medical cannabis. Oren brings more than two decades of proven entrepreneurial experience in founding and growing companies in the med-tech and technology/software industries where healthcare, patient care, technology and innovation intersect.
Prior to IMC, Oren co-founded a small start-up, E-wave, bringing his vision to build a global tech company that provides software solutions for enterprises in digital, IT, HR, and medical technologies. Today, E-wave is a global software house that employs 1,000 professionals with operations in the U.S., Canada, Brazil, India and Israel.
In addition to his entrepreneurial track-record, Oren also held executive positions at a number of companies within the telecom and digital media industries.